Recent literature has begun to highlight a potential role for GPR35 in a number of disease pathologies including hypertension and heart failure [28,29], asthma [38], pain [18,39], inflammatory bowel disease [40] and both ulcerative colitis and primary sclerosing cholangitis [41]. This evidence concerns the gene GPR35 and inflammatory bowel disease.